Scientists have discovered a defensive method of cells that resembles Spiderman shooting his web to ensnare enemies. These ...

Detailed price information for Aligos Therapeutics Inc (ALGS-Q) from The Globe and Mail including charting and trades.

RNA modifications have emerged as a crucial area of research within molecular viral pathogenesis, providing new insights into how viruses hijack host gene ...

RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production. Scientists are now testing a new platform called DoriVac, which uses folded DNA ...

Researchers identify how Marburg virus can efficiently infect human cells, using cryo-EM to demonstrate entry.

A long-running debate in vaccine design revolves around whether a vaccine should be optimized to prevent the virus from replicating inside an infected host or prevent the virus from transmitting to ...

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases ...

Company plans to initiate a pivotal phase 3 clinical trial of aglatimagene besadenovec (aglatimagene or CAN-2409) in patients with progressive, metastatic, non-squamous, non-small cell lung cancer ...

A team of researchers has finally cracked a decades-old mystery in virology: how low-pathogenic avian influenza viruses transform into highly pathogenic strains. The study, published in Science, ...

In a phase 3 clinical trial, the tetravalent dengue vaccine, developed by the Butantan Institute in São Paulo, Brazil, was 80.5% effective against severe dengue cases with warning signs over a ...

Researchers from Indian Institute of Science Education and Research (IISER) Mohali have discovered that unique antibodies ...

CDI-988 is a direct-acting, oral antiviral being developed for norovirusNorovirus challenge study is underway at Emory University School of ...